Drug intelligence / Profile preview

Traumeel + Zeel

Development stage
Unknown
Lead developer
Heel
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Intraarticular
01

Overview

Traumeel + Zeel is a combination homeopathic drug product developed by Biologische Heilmittel Heel GmbH and distributed by MediNatura in the United States. The product consists of two separate homeopathic injection solutions, Traumeel (Tr14) and Zeel (Ze14), which are typically co-administered in a 1:1 ratio via intra-articular injection. Traumeel is composed of 14 natural ingredients, including 12 botanical components such as *Arnica montana*, while Zeel contains sulfur and extracts from four medicinal plants (*Arnica montana*, *Sanguinaria canadensis*, *Rhus toxicodendron*, and *Solanum dulcamara*). The combination is indicated for the treatment of inflammatory and degenerative musculoskeletal conditions, particularly moderate-to-severe knee osteoarthritis and rheumatic joint diseases. While the exact biological mechanism is not fully understood, in vitro studies suggest that the combination may modulate inflammation by inhibiting the cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), and 5-lipoxygenase (5-LOX) pathways, thereby affecting the production of eicosanoids and leukotrienes. Clinical trials, such as the MOZArT study, have demonstrated that the combination offers efficacy comparable to hyaluronic acid and corticosteroids with a favorable safety profile.

Brand names
Traumeel S
Other names
Traumeel/ZeelTr14 + Ze14
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on Traumeel + Zeel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Traumeel + Zeel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call